For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
QQFTEHQIDGVLVVAAVGAVDMLTAPQLQEAINAALDRQPTGVVVDLTAVDFLGSAGMQVLMTTRRQLEG TVKFAVVADGPATSRPLKITGIADYVDLFSTLDVALRNLAG*
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. vanbaalenii PYR-1 | Mvan_4702 | - | - | 100% (112) | anti-sigma-factor antagonist |
| M. vanbaalenii PYR-1 | Mvan_3003 | - | 2e-25 | 54.37% (103) | anti-sigma-factor antagonist |
| M. vanbaalenii PYR-1 | Mvan_1481 | - | 5e-16 | 44.79% (96) | anti-sigma-factor antagonist |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb3712c | - | 5e-13 | 45.83% (72) | hypothetical protein Mb3712c |
| M. gilvum PYR-GCK | Mflv_2021 | - | 1e-44 | 75.89% (112) | anti-sigma-factor antagonist |
| M. tuberculosis H37Rv | Rv3687c | rsfB | 4e-19 | 42.72% (103) | anti-anti-sigma factor RSFB (anti-sigma factor antagonist) |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | - | - | - | - | - |
| M. marinum M | MMAR_5181 | - | 7e-21 | 45.63% (103) | anti-anti-sigma regulatory factor |
| M. avium 104 | MAV_5272 | - | 6e-25 | 49.53% (107) | anti-anti-sigma factor |
| M. smegmatis MC2 155 | MSMEG_6127 | - | 2e-29 | 59.05% (105) | anti-anti-sigma factor |
| M. thermoresistible (build 8) | TH_0498 | - | 2e-26 | 58.00% (100) | anti-anti-sigma factor |
| M. ulcerans Agy99 | MUL_3602 | - | 4e-07 | 32.11% (109) | anti sigma factor antagonist |
CLUSTAL 2.0.9 multiple sequence alignment
Mb3712c|M.bovis_AF2122/97 ------------------------------------------------MA
Rv3687c|M.tuberculosis_H37Rv -------MSAPDSITVTVADHNGVAVLSIGGEIDLITAAALEEAIGEVVA
MMAR_5181|M.marinum_M -------MSAPDSITAVVTDHDGVTVLSIGGEIDLVTAPALEEAIGAVVA
Mvan_4702|M.vanbaalenii_PYR-1 ------------MQQFTEHQIDGVLVVAAVGAVDMLTAPQLQEAINAALD
Mflv_2021|M.gilvum_PYR-GCK ------------MQQFTEREVDGVVIVAAVGAIDMLTAPQLQEAVAAAAR
MSMEG_6127|M.smegmatis_MC2_155 -----MTSQDPANCTVEERRVGDITVVAVTGTVDMLTAPKLEDAIGSAAK
TH_0498|M.thermoresistible__bu --------------VIDERWDADIAVVSATGVVDMLSAPQLDEAIRTALG
MAV_5272|M.avium_104 MGEQPGDLADPTPFEVGKHQVDQAVVLTVSGEVDMLSSPMLAEAVQTALA
MUL_3602|M.ulcerans_Agy99 ----------MDLLAVEHEVRQDTVVVRAKGDVDSSTVEQLVVHLAAAMQ
Mb3712c|M.bovis_AF2122/97 DNPTA----LVIDLSAVEFLGSVGLKILAATSEK-IGQSVKFGVVARGSV
Rv3687c|M.tuberculosis_H37Rv DNPTA----LVIDLSAVEFLGSVGLKILAATSEK-IGQSVKFGVVARGSV
MMAR_5181|M.marinum_M DSPTA----LVIDLSGVEFLGSVGLKILAATYEK-LGTAAEFGVVAQGPA
Mvan_4702|M.vanbaalenii_PYR-1 RQPTG----VVVDLTAVDFLGSAGMQVLMTTRRQ-LEGTVKFAVVADGPA
Mflv_2021|M.gilvum_PYR-GCK RRPSG----LVVDLTSVDFLGSAGMQVLMETRKG-LDGDTRFAVVADGPA
MSMEG_6127|M.smegmatis_MC2_155 SEPSA----VVVDLSAVDFLASAGMGVLVAAHGE-LAPAVRLVVVADGPA
TH_0498|M.thermoresistible__bu KKPRA----LVVDFTAVDFLASAGMGVLVAIHDE-VSPAVNLTIVADGPA
MAV_5272|M.avium_104 AKPAA----LIVDLSKVGFLASAGMTVLVTTQAE-LQPPTKFAVVADGSA
MUL_3602|M.ulcerans_Agy99 LAATHPARLVVIDLQPVTFFGSAGLNAVLECHEQGMAAGTSVRLVADHGQ
. :::*: * *:.*.*: : : . . :**
Mb3712c|M.bovis_AF2122/97 TRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR-------
Rv3687c|M.tuberculosis_H37Rv TRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR-------
MMAR_5181|M.marinum_M TRRPIHLTGLDKTFPLYPALDDALTGVRDGKLNR-------
Mvan_4702|M.vanbaalenii_PYR-1 TSRPLKITGIADYVDLFSTLDVALRNLAG------------
Mflv_2021|M.gilvum_PYR-GCK TSRPLKITGITDYVDLYPSLDVALADLAG------------
MSMEG_6127|M.smegmatis_MC2_155 TSRPLKLVGIADVVDLFATLDEALSSLKT------------
TH_0498|M.thermoresistible__bu TSRPLKLLGIADLVPLHATLDEALAAVAT------------
MAV_5272|M.avium_104 TSRPIKLMGIDSVLSLYPSLNDALSALSGA-----------
MUL_3602|M.ulcerans_Agy99 LLAPIQVTELDRIFEIYPTLAGALRPGKPGEHDLEDVERPR
*::: : . :..:* **